We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
16 hedge funds and large institutions have $1.06M invested in CASI Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
11.02% less ownership
Funds ownership: 21.2% → 10.18% (-11%)
27% less funds holding
Funds holding: 22 → 16 (-6)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
75% less capital invested
Capital invested by funds: $4.33M → $1.06M (-$3.26M)
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
16
Holders Change
-6
Holders Change %
-27.27%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
5
Closed
7
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$1K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$18.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$834 |
| 3 |
Morgan Stanley
New York
|
+$3 |
